These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 26386725)

  • 21. Insulin-like growth factor-II mRNA binding protein-3 and podoplanin expression are associated with bone invasion and prognosis in oral squamous cell carcinoma.
    Hwang YS; Ahn SY; Moon S; Zheng Z; Cha IH; Kim J; Zhang X
    Arch Oral Biol; 2016 Sep; 69():25-32. PubMed ID: 27232357
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stromal transforming growth factor-beta 1 is crucial for reinforcing the invasive potential of low invasive cancer.
    Hwang YS; Park KK; Chung WY
    Arch Oral Biol; 2014 Jul; 59(7):687-94. PubMed ID: 24769314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Podoplanin promotes cell migration via the EGF-Src-Cas pathway in oral squamous cell carcinoma cell lines.
    Inoue H; Miyazaki Y; Kikuchi K; Yoshida N; Ide F; Ohmori Y; Tomomura A; Sakashita H; Kusama K
    J Oral Sci; 2012 Sep; 54(3):241-50. PubMed ID: 23047035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced IMP3 Expression Activates NF-кB Pathway and Promotes Renal Cell Carcinoma Progression.
    Pei X; Li M; Zhan J; Yu Y; Wei X; Guan L; Aydin H; Elson P; Zhou M; He H; Zhang H
    PLoS One; 2015; 10(4):e0124338. PubMed ID: 25919292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular alterations that drive breast cancer metastasis to bone.
    Ottewell PD; O'Donnell L; Holen I
    Bonekey Rep; 2015; 4():643. PubMed ID: 25848532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic and predictive values of EGFR overexpression and EGFR copy number alteration in HER2-positive breast cancer.
    Lee HJ; Seo AN; Kim EJ; Jang MH; Kim YJ; Kim JH; Kim SW; Ryu HS; Park IA; Im SA; Gong G; Jung KH; Kim HJ; Park SY
    Br J Cancer; 2015 Jan; 112(1):103-11. PubMed ID: 25349977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Membrane Proteins Involved in Epithelial-Mesenchymal Transition and Tumor Invasion: Studies on TMPRSS4 and TM4SF5.
    Kim S; Lee JW
    Genomics Inform; 2014 Mar; 12(1):12-20. PubMed ID: 24748857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effective targeting of the epidermal growth factor receptor (EGFR) for treating oral cancer: a promising approach.
    Ribeiro FA; Noguti J; Oshima CT; Ribeiro DA
    Anticancer Res; 2014 Apr; 34(4):1547-52. PubMed ID: 24692681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Afatinib, erlotinib and gefitinib in the first-line therapy of EGFR mutation-positive lung adenocarcinoma: a review.
    Köhler J; Schuler M
    Onkologie; 2013; 36(9):510-8. PubMed ID: 24051929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Axl mediates acquired resistance of head and neck cancer cells to the epidermal growth factor receptor inhibitor erlotinib.
    Giles KM; Kalinowski FC; Candy PA; Epis MR; Zhang PM; Redfern AD; Stuart LM; Goodall GJ; Leedman PJ
    Mol Cancer Ther; 2013 Nov; 12(11):2541-58. PubMed ID: 24026012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The tumor microenvironment contribution to development, growth, invasion and metastasis of head and neck squamous cell carcinomas.
    Koontongkaew S
    J Cancer; 2013; 4(1):66-83. PubMed ID: 23386906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. STC1 expression by cancer-associated fibroblasts drives metastasis of colorectal cancer.
    Peña C; Céspedes MV; Lindh MB; Kiflemariam S; Mezheyeuski A; Edqvist PH; Hägglöf C; Birgisson H; Bojmar L; Jirström K; Sandström P; Olsson E; Veerla S; Gallardo A; Sjöblom T; Chang AC; Reddel RR; Mangues R; Augsten M; Ostman A
    Cancer Res; 2013 Feb; 73(4):1287-97. PubMed ID: 23243022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer-associated fibroblasts drive the progression of metastasis through both paracrine and mechanical pressure on cancer tissue.
    Karagiannis GS; Poutahidis T; Erdman SE; Kirsch R; Riddell RH; Diamandis EP
    Mol Cancer Res; 2012 Nov; 10(11):1403-18. PubMed ID: 23024188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional invadopodia formation through stabilization of the PDPN transcript by IMP-3 and cancer-stromal crosstalk for PDPN expression.
    Hwang YS; Xianglan Z; Park KK; Chung WY
    Carcinogenesis; 2012 Nov; 33(11):2135-46. PubMed ID: 22859271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Accessories to the crime: functions of cells recruited to the tumor microenvironment.
    Hanahan D; Coussens LM
    Cancer Cell; 2012 Mar; 21(3):309-22. PubMed ID: 22439926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of IMP3 by EGFR signaling and repression by ERβ: implications for triple-negative breast cancer.
    Samanta S; Sharma VM; Khan A; Mercurio AM
    Oncogene; 2012 Nov; 31(44):4689-97. PubMed ID: 22266872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidermal growth factor receptor (EGFR) in lung cancer: an overview and update.
    Bethune G; Bethune D; Ridgway N; Xu Z
    J Thorac Dis; 2010 Mar; 2(1):48-51. PubMed ID: 22263017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of insulin-like growth factor-II mRNA-binding protein-3 in invadopodia formation and the growth of oral squamous cell carcinoma in athymic nude mice.
    Hwang YS; Park KK; Cha IH; Kim J; Chung WY
    Head Neck; 2012 Sep; 34(9):1329-39. PubMed ID: 22052854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The tumor microenvironment.
    Weber CE; Kuo PC
    Surg Oncol; 2012 Sep; 21(3):172-7. PubMed ID: 21963199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hallmarks of cancer: the next generation.
    Hanahan D; Weinberg RA
    Cell; 2011 Mar; 144(5):646-74. PubMed ID: 21376230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.